ИСТИНА |
Войти в систему Регистрация |
|
ИПМех РАН |
||
Currently, one of the aims of health care reform in Russia is to fully cover the need of the Russian population for high-tech medical care. This is an important element of long-term health care strategy of the Russian Federation for the period till 2020. This requires an increase in the volume of high-tech care provided, securing its accessibility and bringing it closer to those in need. Under modern health care reforms the provision of HT medical treatment underwent serious changes both in terms of funding and organisaiton. The number of clinics that provide such types of care increased together with federal funding especially during the period between 2006- 2012. At present total funding for high-tech medical care comes from two sources - the mandatory health insurance and the federal and regional budgets. It is planned that starting from 2015 it will be covered from a single source - mandatory health insurance. The aim of the paper is to analyse the current state of affairs, identify the main challenges (institutional and regulatory), connected with the transition high-tech medical care finance under the mandatory health medical insurance from the point of view of both population access and future structure of health care system in Russia. One of the main problems seems to be finding a right balance between HT and other “ordinary” medical treatment under the conditions of funding restrains and attempts to promote primary health care.